Indolent T-Cell Lymphoproliferative Disorder of the Gastrointestinal Tract
specific11
Centers
11
Active Trials
—
Cancer Funding
Top Centers for Indolent T-Cell Lymphoproliferative Disorder of the Gastrointestinal Tract(11)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 54.5 |
| 2 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program | 54.5 |
| 3 | Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive Active Research Program | 54.5 |
| 4 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive Active Research Program | 54.5 |
| 5 | Moffitt Cancer CenterTampa, FL NCI Comprehensive Active Research Program | 54.5 |
| 6 | NCI Clinical Active Research Program | 54.5 |
| 7 | Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical Active Research Program | 54.5 |
| 8 | University of Illinois Cancer CenterChicago, IL Active Research Program | 54.5 |
| 9 | Boston University Cancer CenterBoston, MA Active Research Program | 54.5 |
| 10 | Cancer Center at IllinoisUrbana, IL Active Research Program | 54.5 |
| 11 | Active Research Program | 54.5 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →